The role of alendronate in mitigating perimenopausal bone loss: a double-blind randomized controlled pilot study  

Oleh:

Mersereau, Jennifer E. ; Khouri, Claire ; Jaffe, Robert B.

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: Fertility and Sterility (keterangan: ada di ClinicalKey) vol. 94 no. 03 (Aug. 2010), page 1138-1140.
Topik: Osteoporosis; perimenopause; alendronate

Ketersediaan

Perpustakaan FK Nomor Panggil: F02.K.2010.04 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

Compared with placebo, alendronate treatment resulted in a significant protection against bone loss in healthy perimenopausal women. This protection occurred at both the spine and the hip and was evident after 6 months of therapy.

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali